Aleve Campaign Cites Media Reports Of FDA Advisory Panel Opinions
This article was originally published in The Tan Sheet
Executive Summary
A new ad campaign for Bayer's Aleve touts FDA advisory committee commentary regarding the safety of naproxen in relation to other analgesics
You may also be interested in...
Bayer Attributes Recent Aleve Bounce To Advisory Panel Discussions
Bayer credits a rebound in Aleve sales in March to favorable FDA advisory committee discussions on the safety of naproxen
Bayer Attributes Recent Aleve Bounce To Advisory Panel Discussions
Bayer credits a rebound in Aleve sales in March to favorable FDA advisory committee discussions on the safety of naproxen
Bayer Attributes Recent Aleve Bounce To Advisory Panel Discussions
Bayer credits a rebound in Aleve sales in March to favorable FDA advisory committee discussions on the safety of naproxen